Literature DB >> 3714057

Systemic carnitine deficiency due to lack of electron transfer flavoprotein:ubiquinone oxidoreductase.

S Di Donato, F E Frerman, M Rimoldi, P Rinaldo, F Taroni, U N Wiesmann.   

Abstract

A child with myopathy and systemic carnitine deficiency died at age 8 years in an acute metabolic attack. He had glutaric aciduria type II, and his cultured fibroblasts contained normal activity of four different acyl CoA dehydrogenases, but there was deficiency of electron transfer flavoprotein:ubiquinone oxidoreductase (ETF-QO). This enzyme is thought to reduce coenzyme Q in the respiratory chain, funneling reducing equivalents from seven flavoproteins in the beta-oxidation of acyl CoAs. There was massive urinary excretion of the short-chain acylcarnitines that accumulated in mitochondria as a result of the ETF-QO defect. Carnitine therefore acts as a buffer for excessive accumulation of intramitochondrial acyl CoAs, and defective beta-oxidation can cause carnitine insufficiency.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3714057     DOI: 10.1212/wnl.36.7.957

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

Review 1.  Mitochondrial myopathies.

Authors:  S DiMauro; E Bonilla; M Zeviani; S Servidei; D C DeVivo; E A Schon
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

Review 2.  Primary lipid cardiomyopathy.

Authors:  A Zimmermann; P Wyss; F Stocker
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 3.  Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.

Authors:  J Osterloh; W Cunningham; A Dixon; D Combest
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

4.  The importance of recognizing secondary carnitine deficiency in organic acidaemias: case report in glutaric acidaemia type II.

Authors:  H Mandel; D Africk; M Blitzer; E Shapira
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

5.  4-Hydroxybutyric aciduria: clinical findings and vigabatrin therapy.

Authors:  G Uziel; P Bardelli; C Pantaleoni; M Rimoldi; M Savoiardo
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

6.  Muscle cytochrome c oxidase deficiency in two Italian patients with ethylmalonic aciduria and peculiar clinical phenotype.

Authors:  B Garavaglia; V Colamaria; F Carrara; P Tonin; M Rimoldi; G Uziel
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

7.  A new stable-isotope dilution method for measurement of orotic acid utilizing solvent-extracted urine.

Authors:  M Rimoldi; P Bergomi; A Romeo; S DiDonato
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

Review 8.  Defects of fatty acid oxidation in skeletal muscle.

Authors:  D M Turnbull; K Bartlett; N J Watmough; I M Shepherd; H S Sherratt
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

9.  Lipid-storage myopathy and respiratory insufficiency due to ETFQO mutations in a patient with late-onset multiple acyl-CoA dehydrogenation deficiency.

Authors:  R K J Olsen; M Pourfarzam; A A M Morris; R C Dias; I Knudsen; B S Andresen; N Gregersen; S E Olpin
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

10.  Newborn Screening for Glutaric Aciduria-II: The New England Experience.

Authors:  I Sahai; C L Garganta; J Bailey; P James; H L Levy; M Martin; E Neilan; C Phornphutkul; D A Sweetser; T H Zytkovicz; R B Eaton
Journal:  JIMD Rep       Date:  2013-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.